These strange-looking, two-legged robots might be the predecessor of a machine that someday helps with chores around the home.
The bipedal bot, which has yet to be named, was developed by Schaft, a Japanese robotics company that is part of X, the research lab owned by Alphabet (previously Google). It was revealed at an event in Japan hosted by Andy Rubin, who started Google’s robotics project before leaving the company at the end of 2014 to create his own hardware incubator.
A video shot by someone at the event shows the robot carrying a heavy-looking gym weight, slipping on a tube without falling over, and cleaning a set of stairs with a vacuum cleaner brush attachment on its feet. It can also be seen walking through a forest and along a rocky beach.
It looks like the robot’s low center of gravity might help with its dynamic balancing. Usually such robots are very power-hungry, so it would be interesting to know how much that helps with power consumption.
The demo is especially interesting in light of Alphabet’s decision to sell off another robotics company, Boston Dynamics, that's working on walking robots. Perhaps the fact that Schaft’s robot is seen doing housework is a sign that Alphabet thinks it can commercialize the company’s technology sooner.
Schaft was spun out of the JSK Robotics Laboratory at the University of Tokyo, and one of the company’s robots took part in the first stage of DARPA’s Robotic Challenge. In fact, Schaft’s robot dominated the competition, demonstrating remarkable control, dynamic balance, and power-efficiency. But it was withdrawn by Google from the second stage of the contest for undisclosed reasons.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.